Monitoring the SiRNA Release from Lipid Nanoparticles Based on the Fluorescence Resonance Energy Transfer Principle
Overview
Authors
Affiliations
The siRNA-loaded lipid nanoparticles have attracted much attention due to its significant gene silencing effect and successful marketization. However, the distribution and release of siRNA still cannot be effectively monitored. In this study, based on the fluorescence resonance energy transfer (FRET) principle, a fluorescence dye Cy5-modified survivin siRNA was conjugated to nanogolds (Au-DR-siRNA), which were then wrapped with lipid nanoparticles (LNPs) for monitoring the release behaviour of siRNA . The results showed that once Au-DR-siRNA was released from the LNPs and cleaved by the Dicer enzyme to produce free siRNA in cells, the fluorescence of Cy5 would change from quenched state to activated state, showing the location and time of siRNA release. Besides, the LNPs showed a significant antitumor effect by silencing the survivin gene and a CT imaging function superior to iohexol by nanogolds. Therefore, this work provided not only an effective method for monitoring the pharmacokinetic behaviour of LNP-based siRNA, but also a siRNA delivery system for treating and diagnosing tumors.
Duangchan K, Limjunyawong N, Rodponthukwaji K, Ittiudomrak T, Thaweesuvannasak M, Kunwong N ACS Bio Med Chem Au. 2025; 5(1):78-88.
PMID: 39990947 PMC: 11843345. DOI: 10.1021/acsbiomedchemau.4c00061.
Long S, Turner D, Hamill K, Natrajan L, McDonald T J Mater Chem B. 2025; 13(7):2295-2305.
PMID: 39886899 PMC: 11783621. DOI: 10.1039/d4tb02653e.
Advanced bioanalytical techniques for pharmacokinetic studies of nanocarrier drug delivery systems.
Meng X, Yao J, Gu J J Pharm Anal. 2025; 15(1):101070.
PMID: 39885973 PMC: 11780097. DOI: 10.1016/j.jpha.2024.101070.
Remodeling the tumor immune microenvironment via siRNA therapy for precision cancer treatment.
Jiang L, Qi Y, Yang L, Miao Y, Ren W, Liu H Asian J Pharm Sci. 2023; 18(5):100852.
PMID: 37920650 PMC: 10618707. DOI: 10.1016/j.ajps.2023.100852.
Advances with Lipid-Based Nanosystems for siRNA Delivery to Breast Cancers.
Subhan M, Filipczak N, Torchilin V Pharmaceuticals (Basel). 2023; 16(7).
PMID: 37513882 PMC: 10386415. DOI: 10.3390/ph16070970.